Delivery Order SPE2DB22D2005-SPE2DB25FJRD5
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,408.25 on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-competitive delivery order, with a completion date of July 29, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle supporting federal medical procurement needs. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,700.12 on July 28, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injections. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors valued at $7,605.13. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,644.62 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 25, 2025, with a completion date of July 28, 2025. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting the federal government's...
- The Defense Logistics Agency has awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections in 0.5 ml units. This firm fixed-price delivery order, issued on August 4, 2025, with completion targeted for August 5, 2025, represents a small-value pharmaceutical procurement under DLA's medical supply chain operations. The award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,720.90 on July 28, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,305.04 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order is scheduled for completion by July 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,888.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a continuation of the company's critical role as a pharmaceutical supplier to federal military and healthcare systems. The place of performance...
- The Defense Logistics Agency awarded a $2,431.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectables on July 24, 2025, with an ultimate completion date of July 25, 2025. This contract represents a non-set-aside competitive award for pharmaceutical supply to federal healthcare systems. The award was performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major hub for...
- The Defense Logistics Agency awarded a $2,148.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections. This is a non-set-aside contract with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement to support federal medical supply requirements, consistent with the Defense...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRD5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections on August 8, 2025, with a ceiling value of $2,176.72 and an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a prime contractor under the DLA Troop Support Medical IDC, AmerisourceBergen is positioned to supply pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the Defense Logistics Agency planning to establish additional regional Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple award recipients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/8/25 |